Latest News

Q1 2023 Watch: Tennessee rejecting federal HIV funding; updates on ADAPs, Medicaid, veterans care, and harm reduction.

Tennessee rejects $8.3M in federal HIV prevention funding, threatening surveillance and care programs.

Place-based sexual health care in community venues advances HIV/HCV prevention and testing outreach.

Nevada expands syringe vending machines with naloxone, fentanyl strips; anonymity critical for uptake.

Q4 2022 Watch: HHS renewed opioid emergency; CANN launched monkeypox project; HEPLISAV-B hepatitis B vaccine covered.

S.4395 would divert Ryan White resources from PLWHA to PrEP, threatening the safety net for vulnerable populations.

Sustainable advocacy requires long-term investment beyond quarterly financial commitments.

PrEP access remains limited by payer practices like prior authorizations despite ACA coverage requirements.

CANN campaign promotes transgender leadership in HIV advocacy, affirming gender-affirming care as lifesaving.

CDC updates STI treatment guidelines; ACIP recommends universal adult HBV vaccination and HPV catch-up.

Global Fund report shows COVID-19 reduced HIV/HCV program efficacy while South Africa tripled ART coverage.

COVID-19 strains public health efforts addressing HIV outbreaks, diverting resources from the domestic epidemic.

Merck-Gilead partnership on long-acting injectables Islatravir and Lenacapavir for HIV treatment.